RFPL1
Ret finger protein-like 1
Also known as: RFPL1_HUMAN, RNF78
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75677
- Gene
- RFPL1
- Ensembl
- ENSG00000128250
- Chromosome
- 22
- Canonical length
- 317 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Plasma membrane
OverviewNCBI Gene
Predicted to enable ubiquitin protein ligase activity. Involved in negative regulation of G2/M transition of mitotic cell cycle and positive regulation of proteasomal ubiquitin-dependent protein catabolic process. Located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
317 residues, UniProt reviewed canonical sequence.
>O75677|RFPL1
1 MKRLSLVTTN RLSPHGNFLP LCTFPLAVDM AALFQEASSC PVCSDYLEKP MSLECGCAVC
61 FKCINSLQKE PHGEDLLCCC CSMVSQKNKI RPSWQLERLA SHIKELEPKL KKILQMNPRM
121 RKFQVDMTLD ADTANNFLLI SDDLRSVRSG CITQNRQDLA ERFDVSICIL GSPRFTCGRH
181 YWEVDVGTST EWDLGVCRES VHRKGRIHLT TERGFWTVSL RDGSRLSAST VPLTFLFVDR
241 KLQRVGIFLD MGMQNVSFFD AEGGSHVYTF RSVSAEEPLH LFFAPPSPPN GDKSVLSICP
301 VINPGTTDAP VHPGEAKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RFPL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 16 nTPM
- retina: 2.8 nTPM
- adrenal gland: 2.7 nTPM
- testis: 1.7 nTPM
- prostate: 1.2 nTPM
- liver: 1 nTPM
Single-cell type
- early spermatids: 10 nCPM
- prostatic glandular cells: 9.5 nCPM
- retinal ganglion cells: 3.9 nCPM
- late primary spermatocytes: 2.8 nCPM
- other brain neurons: 1.1 nCPM
- brain excitatory neurons: 1 nCPM
Immune cell
- naive B-cell: 0.5 nTPM
- non-classical monocyte: 0.3 nTPM
- T-reg: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
Brain region
- cerebral cortex: 61 nTPM
- white matter: 42 nTPM
- basal ganglia: 40 nTPM
- hippocampal formation: 38 nTPM
- amygdala: 30 nTPM
- thalamus: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.69
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- innate immune response
- negative regulation of G2/M transition of mitotic cell cycle
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- regulation of gene expression
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, RING-type
- B30.2/SPRY domain
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Zinc finger, RING/FYVE/PHD-type
- Concanavalin A-like lectin/glucanase domain superfamily
- RDM domain, Ret finger protein-like
- Ret finger protein-like, SPRY/PRY domain
- B30.2/SPRY domain superfamily
- Tripartite motif-containing
- SPRY domain
- RFPL defining motif (RDM)
- SPRY-associated domain
- zinc finger of C3HC4-type, RING
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RFPL1 as an antibody target. Whether an autoantibody or antibody against RFPL1 could matter depends on whether native RFPL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RFPL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RFPL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...